Abstract
Introduction
Management of coronary anomalies continues to be a controversial topic in medicine, for which only in specific clinical scenarios recommendations for management are clearly defined. We are presenting a previously healthy 18-year-old patient who survived sudden cardiac death (SCD). Multiple potential aetiologies were evaluated, including malignant coronary anomaly, acute myocarditis, potential Brugada type 3 electrocardiographic pattern, and urine drug screening positive for lysergic acid diethylamide (LSD).
Case presentation
Malignant right coronary anomaly with interarterial course and acute angle takeoff was diagnosed with coronary computed tomography angiography. Signs of acute myocarditis were detected in cardiac magnetic resonance imaging and endomyocardial biopsy. Due to potential Brugada type 3 electrocardiographic pattern flecainide provocation testing was performed to rule out Brugada Syndrome. Confirmatory chromatography revealed that prior LSD drug screening was false positive. Ultimately, the patient underwent cardiothoracic surgery with unroofing of the right coronary artery. Subsequent clinical course was favourable.
Discussion
Right coronary artery anomalies are more prevalent than left coronary anomalies but less often associated with SCD. Interarterial course and acute angle takeoff are risk factors for unfavourable outcomes. Myocarditis is a potential trigger of arrhythmias and SCD. In patients with Brugada type 2 and 3 electrocardiographic pattern (saddleback ST-segment elevation), provocation testing with flecainide, ajmalin, or procainamide can be used to unmask Brugada type 1 electrocardiographic pattern. Due to the proarrythmic potential of many recreational drugs, screening for these substances can be useful in young adults presenting after cardiac arrest; cross-reaction of substances as in our patient have to be considered.
Keywords: Case report, Coronary anomaly, Myocarditis, Brugada ECG
Learning points
Coronary anomalies have been associated with sudden cardiac death (SCD) in young adults. Right coronary artery anomalies are more prevalent than left coronary artery anomalies but less often associated with SCD. Moreover, interarterial course and acute angle takeoff are risk factors for unfavourable outcomes.
Acute myocarditis is associated with increased risk of arrhythmias and SCD.
Introduction
Sudden cardiac death (SCD) is mainly caused by ventricular arrhythmia and accounts for 30% of sudden deaths in young adults of age 14–21 years.1,2 Possible aetiologies of SCD in this population include ischaemic heart disease, cardiomyopathies, congenital heart disease, primary electrophysiological abnormalities (including long QT and Brugada syndrome), myocarditis, aortic dissection, cardiac tamponade, acute myocardial rupture, and non-cardiac causes (such as pulmonary embolism, intracranial haemorrhage, or drug overdose and toxicity).1
Timeline
| Timeline diagnostic workup and therapy | |
|---|---|
| Day 1 | Out-of-hospital resuscitation. Presentation of a vasopressor-dependent, intubated patient. Electrocardiogram: right bundle branch block morphology, T wave inversions and ST-segment elevation in V3 and V4. Cranial, cervical, and thoracic computed tomography: no signs of intracranial bleeding, cervical spine injury or pulmonary embolism. Transthoracic echocardiography: diffuse hypokinesis, severely reduced left ventricular ejection fraction (LVEF). Mechanical ventilation and antibiotic therapy (due to aspiration and acute respiratory distress syndrome) |
| Day 2 | Coronary angiography and endomyocardial biopsy: negative for coronary artery disease in the left coronary system, unable to engage the right coronary system. Transthoracic echocardiography: Diffuse hypokinesis, LVEF 29% |
| Day 3 | Coronary computed tomography: anomalous right coronary artery arising from the left sinus of Valsalva with acute angle takeoff and interarterial course between aorta and pulmonary artery |
| Day 5 | Successful weaning and extubation |
| Day 10 | Cardiac magnetic resonance imaging: Borderline myocarditis, anterolateral hypokinesis with circular pericardial effusion, normalized LVEF |
| Day 16 | Negative Brugada provocation testing |
| Day 20 | Successful cardiothoracic surgery |
| Day 25 | Start of cardiac rehabilitation with a wearable cardioverter-defibrillator |
| Day 157 | Implantation of subcutaneous implantable cardioverter-defibrillator |
Case presentation
A healthy 18-year-old woman lost consciousness while trying to catch the bus on her birthday. She was found with pulseless ventricular fibrillation (VF) upon arrival of emergency services. After four defibrillations with 200 Joules, adrenaline 3 mg, and amiodarone 300 mg intravenously (IV), the patient developed return of spontaneous circulation 15 min later. She was intubated and brought to the emergency department.
Cardiovascular exam findings revealed a patient with cool, mottled skin, euvolemic with normal heart sounds, and no murmurs on auscultation. Lungs were fully expanding and clear to auscultation. The patient was vasopressor-dependent and intubated on assist-control ventilation. Physical cooling procedures were started immediately.
A 12-lead electrocardiogram (ECG) was obtained (Figure 1) and demonstrated sinus rhythm at approximately 110 b.p.m. with right bundle branch block morphology, negative T-waves, and ST-segment elevation in V3 and V4. Laboratory tests revealed leucocytosis (17 G/L, normal 3.0–9.6 G/L), elevated CRP (37 mg/L, normal <5 mg/L), and peak high sensitivity troponin T of 274 ng/L (normal <14 ng/L). Urine drug screening was positive for lysergic acid diethylamide (LSD). Confirmatory chromatography revealed that this was a false positive result due to cross-reaction with fentanyl, which had been administered several hours prior upon arrival to the emergency department. Initial transthoracic echocardiography was consistent with diffuse hypokinesis and reduced left ventricular ejection fraction (LVEF) of 29%. The patient underwent computed tomography to exclude intracranial bleeding, cervical spine injury and pulmonary embolism. Coronary angiography was negative for obstructive coronary artery disease in the left coronary system. Since the right coronary system could not be engaged via catheter, a coronary computed tomography was ordered to evaluate for coronary anomalies. Indeed, an anomalous right coronary artery (RCA) was identified arising from the left sinus of Valsalva with acute angle takeoff and interarterial course between aorta and pulmonary artery (Figure 2).
Figure 1.
Initial 12-lead electrocardiogram (25 mm/s, 10.0 mm/mV).
Figure 2.
Coronary computed tomography: right coronary artery (arrow) arising from the left sinus of Valsalva with acute angle takeoff and interarterial course between aorta and pulmonary artery.
Due to recent rhinovirus infection and a history suggestive for myocarditis, an endomyocardial biopsy was obtained on day 2 and cardiac magnetic resonance imaging (CMR) on day 10, revealing borderline myocarditis, anterolateral hypokinesia with circular pericardial effusion and normalized LVEF. Only mild signs of inflammation without recurrence of arrhythmias during telemetry monitoring suggested that myocarditis was less likely the sole aetiology of the patient’s cardiac arrest. However, the inflammation could have lowered the threshold for arrhythmias and may have been the trigger for cardiac arrest on the grounds of an already predisposing condition—coronary anomaly.
Given suspicion for potential Brugada type 3 ECG pattern (<2 mm saddleback ST-segment elevation), the patient underwent Brugada Syndrome provocation testing with flecainide (2 mg/kg continuous IV infusion over 10 minutes, Figure 3). No obvious signs for Brugada type 1 ECG pattern were revealed with this test.
Figure 3.
12-lead electrocardiogram after intravenously flecainide without typical type 1 ST-segment elevation Brugada pattern (25 mm/s, 10.0 mm/mV). Leads V5 and V6 are modified right precordial leads at higher intercostal space positions.
Acute respiratory distress syndrome after aspiration was treated in the intensive care unit. Ultimately, after all reversible causes for the patient’s cardiac arrest had been ruled out, the patient underwent cardiothoracic surgery 20 days post admission with unroofing of the RCA and a wearable cardioverter-defibrillator (WCD) was installed to bridge until implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention.
Neurological course was favourable with no remaining neurological deficit and cardiothoracic surgery was successful. An S-ICD was implanted 5 months after the cardiac arrest.
Due to persistent, haemodynamically not relevant pericardial effusion, oral therapy with non-steroidal anti-inflammatory drug (naproxen 500 mg twice a day), and colchicine (0.5 mg once a day) was initiated.
Discussion
Anomalous origin of a coronary artery from the opposite sinus of Valsalva has been associated with SCD in young adults. The prevalence of RCA arising from the left sinus of Valsalva is higher than the left coronary artery (LCA) branching from the right sinus of Valsalva,3 but less frequently associated with SCD.4 It was hypothesized that SCD may occur due to sudden occlusion of the affected coronary artery because of its unusual course with consecutive myocardial ischemia, ventricular tachycardia or fibrillation.4 Young adults <30 years old are at highest risk4 and given a possible genetic element for coronary anomalies first degree relative screening should be considered.5
An interarterial course of an anomalous coronary artery between aorta and pulmonary artery is a class IB indication for surgical repair in documented LCA anomaly, whereas in documented RCA anomaly it is with evidence of ischaemia.6 Therapy in asymptomatic young patients with RCA arising from the left sinus of Valsalva with acute angle takeoff and interarterial course and without evidence for stress induced ischaemia is controversial. While some experts recommend medical therapy (beta and calcium antagonists, nitrates, antiarrhythmic drugs) in older patients7 with or without restriction from vigorous exercise, others generally recommend surgery in particular in teenagers with a coronary anomaly.8 The risk of SCD has to be balanced against perioperative risks.9 Since there are no clear guidelines for these clinical circumstances, the decision about further management continues to be on an individual basis. Preventive ICD-implantation has the limitation of not protecting against ischaemia.
In our patient, given the presence of a right dominant coronary system, interarterial course and status post cardiac arrest we decided for surgical correction. There are no guidelines for ICD implantation after surgical correction in patients with preserved LVEF. While anomaly of the coronary artery may be the reversible cause for SCD, it could be possible that it is only a bystander and part of a syndrome that predisposes to arrhythmias, for example a syndrome entailing a channelopathy. Subcutaneous implantable cardioverter-defibrillator has been proven effective in primary and secondary prevention with no risk of lead-related long-term complications making it particularly valuable in young age.10 While awaiting an ICD implantation or if the risk of SCD is transient in well-selected patient a WCD is a non-invasive bridging modality.11
This case report presents a rare case with a broad spectrum of differential diagnoses. A limitation of this case is that we could not definitively exclude another non-reversible cause of SCD despite extended diagnostic workup.
Other investigated differential diagnoses were Brugada syndrome, myocarditis, and LSD-intoxication. Clinical manifestations of Brugada syndrome are VF, SCD, syncope, and palpitations. Brugada syndrome is diagnosed in the presence of type 1 ST-segment elevation (coved ST-segment elevation >2 mm in >1 of lead V1–V3 followed by a negative T-wave) spontaneously or after application of a sodium channel blocker. In patients with Brugada type 2 and 3 ECG pattern (saddleback ST-segment elevation), provocation testing with flecainide, ajmalin, or procainamide can be used to unmask Brugada type 1 ECG pattern. Due to its proarrhythmic potential, testing requires a monitored setting.12
Also in myocarditis rhythm monitoring is recommended as clinical course may be complicated by tachyarrhythmia and SCD. There are infectious and non-infectious triggers of myocarditis. Due to inflammation and resultant cell break down of cardiomyocytes, troponins, and inflammatory markers are often elevated. Evaluation for myocarditis includes endomyocardial biopsy or CMR.13
Furthermore, cardiovascular complications have been reported in the context of LSD.14,15
Conclusion
Coronary anomalies have been associated with SCD in young adults.
Right coronary artery anomalies are more prevalent than LCA anomalies but less often associated with SCD. Moreover, interarterial course and acute angle takeoff are risk factors of unfavourable outcomes. Acute myocarditis is associated with increased risk of arrhythmias and SCD.
Funding
This work was supported from the Forschungskredit of the University of Zurich FK-17-047 and the Holcim Foundation (Holcim Stiftung zur Förderung der wissenschaftlichen Fortbildung, Switzerland) issued to Bettina Heidecker.
Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance.
Conflict of interest: none declared.
References
- 1. Kuriachan VP, Sumner GL, Mitchell LB.. Sudden cardiac death. Curr Probl Cardiol 2015;40:133–200. [DOI] [PubMed] [Google Scholar]
- 2. Neuspiel DR, Kuller LH.. Sudden and unexpected natural death in childhood and adolescence. JAMA 1985;254:1321–1325. [PubMed] [Google Scholar]
- 3. Yamanaka O, Hobbs RE.. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn 1990;21:28–40. [DOI] [PubMed] [Google Scholar]
- 4. Taylor AJ, Rogan KM, Virmani R.. Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol 1992;20:640–647. [DOI] [PubMed] [Google Scholar]
- 5. Brothers JA, Stephens P, Gaynor JW, Lorber R, Vricella LA, Paridon SM.. Anomalous aortic origin of a coronary artery with an interarterial course: should family screening be routine? J Am Coll Cardiol 2008;51:2062–2064. [DOI] [PubMed] [Google Scholar]
- 6. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD.. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008;118:2395–2451. [DOI] [PubMed] [Google Scholar]
- 7. Kaku B, Shimizu M, Yoshio H, Ino H, Mizuno S, Kanaya H, Ishise S, Mabuchi H.. Clinical features of prognosis of Japanese patients with anomalous origin of the coronary artery. Jpn Circ J 1996;60:731–741. [DOI] [PubMed] [Google Scholar]
- 8. Mainwaring RD, Reddy VM, Reinhartz O, Petrossian E, Punn R, Hanley FL.. Surgical repair of anomalous aortic origin of a coronary artery. Eur J Cardiothorac Surg 2014;46:20–26. [DOI] [PubMed] [Google Scholar]
- 9. Mery CM, Lopez KN, Molossi S, Sexson-Tejtel SK, Krishnamurthy R, McKenzie ED, Fraser CD, Cantor SB.. Decision analysis to define the optimal management of athletes with anomalous aortic origin of a coronary artery. J Thorac Cardiovasc Surg 2016;152:1366–1375.e7. [DOI] [PubMed] [Google Scholar]
- 10. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA.. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010;363:36–44. [DOI] [PubMed] [Google Scholar]
- 11. Barraud J, Cautela J, Orabona M, Pinto J, Missenard O, Laine M, Thuny F, Paganelli F, Bonello L, Peyrol M.. Wearable cardioverter defibrillator: Bridge or alternative to implantation? World J Cardiol 2017;9:531–538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang C-E, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C.. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013;10:1932–1963. [DOI] [PubMed] [Google Scholar]
- 13. Heymans S, Eriksson U, Lehtonen J, Cooper LT.. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol 2016;68:2348–2364. [DOI] [PubMed] [Google Scholar]
- 14. Nepal C, Patel S, Ahmad N, Mirrer B, Cohen R. Out of Hospital Cardiac Arrest Triggered by LSD in a Patient with Suspected Brugada Syndrome. ATS 2017. Washington, DC: American Journal of Respiratory and Critical Care Medicine; 2017. p. A3773.
- 15. Ghuran A, van Der Wieken LR, Nolan J.. Cardiovascular complications of recreational drugs. BMJ 2001;323:464–466. [DOI] [PMC free article] [PubMed] [Google Scholar]



